Disbandment of Committee. Upon completion (or earlier termination) of the Research Program, the Committee shall be disbanded and shall have no further authority with respect to the activities hereunder.
Appears in 2 contracts
Samples: Exclusive License and Research Collaboration Agreement (Proteostasis Therapeutics, Inc.), License and Research Collaboration Agreement (Cocrystal Pharma, Inc.)
Disbandment of Committee. Upon completion (or earlier termination) of the Research Program, the Committee shall have a final meeting to review the results of the Research Program, shall then be disbanded with no further action by the Committee or the Parties, and shall thereafter have no further authority with respect to the activities hereunderunder this Agreement.
Appears in 2 contracts
Samples: Research Collaboration and Exclusive License Agreement (Janux Therapeutics, Inc.), Research Collaboration and Exclusive License Agreement (Foghorn Therapeutics Inc.)
Disbandment of Committee. Upon completion (or earlier termination) of the Research Program, the Committee shall have a final meeting to review the results of the Research Program, shall then be disbanded with no further action by the Committee or the Parties and shall have no further authority with respect to the activities hereunderunder this Agreement.
Appears in 2 contracts
Samples: Research Collaboration and Option to License Agreement (4D Pharma PLC), Research Collaboration and Option to License Agreement (4D Pharma PLC)
Disbandment of Committee. Upon completion (or earlier termination) of the Research Program, the Committee shall be disbanded and shall have no further authority with respect to the activities hereunder. The Committee shall be disbanded upon expiration of the term of the License Option.
Appears in 1 contract
